Integrated Wealth Management (Palm Desert)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-634	Closed	-$42K	–	1017
2016 Q3	$42K	Buy	634 +59	+10%	+$3.65K	0.02%	446
2016 Q2	$31K	Hold	575	–	–	0.01%	502
2016 Q1	$30K	Hold	575	–	–	0.01%	472
2015 Q4	$40K	Hold	575	–	–	0.02%	436
2015 Q3	$36K	Buy	575 +545	+1,817%	+$42.9K	0.02%	441
2015 Q2	$3K	Buy	+30	New	+$2.33K	﹤0.01%	1084

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s XBI Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2016, closing a stake of 634 shares — an estimated $42K sold.

Integrated Wealth Management (Palm Desert) first reported a position in XBI in Q2 2015 and held it in 6 quarters. The position peaked at $42K in Q3 2016. 274 funds tracked by Wall St. Rank hold XBI as of Q4 2016.

Integrated Wealth Management (Palm Desert) reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2016 after selling out during the quarter.
Integrated Wealth Management (Palm Desert) sold 634 State Street SPDR S&P Biotech ETF shares in Q4 2016, an estimated $42K.
Integrated Wealth Management (Palm Desert) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 6 quarters.
Integrated Wealth Management (Palm Desert)'s State Street SPDR S&P Biotech ETF position peaked at $42K in Q3 2016.
274 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.